Afuco™ Anti-Human FGF21 ADCC Therapeutic Antibody (ARX618), ADCC Enhanced
Anti-FGF21 ADCC Enhanced Antibody (ARX618) is an ADCC enhanced antibody produced by our Afuco™ platform. ARX618 is an antibody binds to Fibroblast Growth Factor 21 (FGF-21) protein, used for the treatment of diabetes and heart failure.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-267CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |
| Target | FGF21 |
| Species Reactivity | Human |